EXEMESTANE (AROMASIN) TABLET – TREATMENT FOR BREAST CANCER
Exemestane or Aromasin 25 mg Tablet is used to treat early-stage breast cancer in postmenopausal women and women who have previously been treated with tamoxifen for 2 to 3 years with no clinical response. Patients who are vitamin D deficient should take vitamin D supplements while taking this medication.
USES OF EXEMESTANE (AROMASIN) TABLET
- Breast Cancer
WORKS OF EXEMESTANE (AROMASIN) TABLET
This medication is used to treat early-stage breast cancer in postmenopausal women and women who have been on tamoxifen for 2 to 3 years with no clinical response.
SIDE EFFECTS OF EXEMESTANE (AROMASIN) TABLET
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Shortness of breath
- Chest pain
- Hot flushes
- Increased sweating
- Mental depression
- Bone and joint pain
- Trouble sleeping
- Swelling of ankles or feet
- Difficult or painful urination
WARNING & PRECAUTIONS
Aromasin 25 mg Tablet normally has no effect on your ability to drive.
In patients with kidney problems, Aromasin 25 mg Tablet is safe to use. There is no need to change the dose of Aromasin 25 mg Tablet.
However, if you have any underlying kidney illness, please notify your doctor.
There is little data on the use of Aromasin 25 mg Tablet in patients with liver disease. Please consult your physician.
Fedelty Health Care is an Exemestane third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.